Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCS.L Regulatory News (SCS)

  • There is currently no data for SCS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - AXA INVESTMENT MANAGERS: ScS Group Plc

1 Nov 2023 09:38

Form 8.3 - AXA INVESTMENT MANAGERS: ScS Group Plc

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:AXA Investment Managers S.A.
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. 
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeScS Group plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: 
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure31 October 2023
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”N/A

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:0.1p ordinary
 InterestsShort positions
 Number%Number%
(1) Relevant securities owned and/or controlled:900,0002.65%  
(2) Cash-settled derivatives:    
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:    
TOTAL: 900,0002.65%  

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists: 
Details, including nature of the rights concerned and relevant percentages: 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
0.1p ordinarysale90,000GBP 2.70

(b) Cash-settled derivative transactions

Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
     

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit
        

(ii) Exercise

Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
     

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)
    

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:1 November 2023
Contact name:Rena Kam
Telephone number*:+852 22852073

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
22nd Mar 20227:00 amRNSInterim Results
16th Mar 20224:36 pmRNSPrice Monitoring Extension
9th Mar 20224:36 pmRNSPrice Monitoring Extension
4th Feb 20224:36 pmRNSPrice Monitoring Extension
3rd Feb 20227:00 amRNSInterim Trading Update
17th Jan 202210:10 amRNSChange of Director Responsibilities
17th Dec 20218:16 amRNSNotification of PDMR Transaction
10th Dec 20217:00 amRNSEmployee Benefit Trust Share Purchase
6th Dec 20212:34 pmRNSEmployee Benefit Trust Share Purchase
30th Nov 20217:00 amRNSDeath of Non-Executive Director
26th Nov 20214:25 pmRNSResult of AGM
26th Nov 20217:00 amRNSAGM Trading Update
26th Oct 20217:00 amRNSAnnual Report and Notice of AGM
25th Oct 202110:21 amRNSPurchase of Shares by Employee Benefit Trust
19th Oct 20214:36 pmRNSGrant of Awards
19th Oct 20214:32 pmRNSVesting of 2019 LTIP awards and PDMR notifications
15th Oct 20214:35 pmRNSPrice Monitoring Extension
5th Oct 20217:00 amRNSPreliminary Results
5th Aug 20217:00 amRNSFull Year Trading Update
18th Jun 20217:00 amRNSInterim Dividend Payment Date
16th Jun 20217:00 amRNSTrading Update
9th Jun 20219:04 amRNSNotification of Major Holdings
7th May 20214:36 pmRNSPrice Monitoring Extension
26th Mar 20215:06 pmRNSDirector/PDMR Shareholding
16th Mar 20215:54 pmRNSDirector/PDMR Shareholding
16th Mar 20217:00 amRNSInterim Results
25th Feb 20217:30 amRNSDirector Declaration
9th Feb 202112:11 pmRNSDirector/PDMR Shareholding
8th Feb 20214:36 pmRNSPrice Monitoring Extension
27th Jan 20217:00 amRNSHalf Year Trading Update
13th Jan 20217:00 amRNSPurchase of Shares by Employee Benefit Trust
6th Jan 20215:43 pmRNSNotification of Major Holdings
5th Jan 20217:00 amRNSPurchase of Shares by Employee Benefit Trust
23rd Dec 20207:00 amRNSPurchase of Shares by Employee Benefit Trust
17th Dec 20207:00 amRNSPurchase of Shares by Employee Benefit Trust
4th Dec 20207:00 amRNSNotification of Major Holdings
25th Nov 20204:35 pmRNSResult of AGM
25th Nov 20207:00 amRNSAGM Statement & Board Changes
10th Nov 20204:41 pmRNSSecond Price Monitoring Extn
10th Nov 20204:36 pmRNSPrice Monitoring Extension
26th Oct 20207:00 amRNSAnnual Report and Notice of AGM
13th Oct 20207:00 amRNSGrant of Awards
29th Sep 20207:00 amRNSPreliminary Results
10th Sep 20207:00 amRNSNotification of Major Holdings
8th Sep 20207:00 amRNSTRADING UPDATE
25th Aug 20204:41 pmRNSSecond Price Monitoring Extn
25th Aug 20204:36 pmRNSPrice Monitoring Extension
30th Jul 20207:00 amRNSTRADING UPDATE
3rd Jul 20207:00 amRNSCompany Secretary Change
18th Jun 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.